Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06302660

Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to learn about long term symptoms in oesophageal cancer survivors. The main question it aims to answer is are: * Study the changes in gut bacteria by examining saliva, stool and blood. * Investigate the products of bacteria in breath to develop a non-invasive breath test to detect the changes in gut bacteria. * Develop new strategies to treat this change and trial new treatments to improve quality- of-life in oesophageal cancer survivors. Participants will attend an outpatient clinic, fasted for at least 4 hours for collection of breath, saliva, blood, urine, stool and complete validated healthy-related quality-of-life questionnaires. Researchers will compare symptomatic and asymptomatic participants to detect the changes stated above.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBreath testParticipants will attend an outpatient clinic, fasted for at least 4 hours for collection of breath.
DIAGNOSTIC_TESTSaliva sampleParticipants will attend an outpatient clinic, fasted for at least 4 hours for collection of saliva.
DIAGNOSTIC_TESTBlood sampleParticipants will attend an outpatient clinic, fasted for at least 4 hours for collection of blood.
DIAGNOSTIC_TESTUrine sampleParticipants will attend an outpatient clinic, fasted for at least 4 hours for collection of urine.
DIAGNOSTIC_TESTStool sampleParticipants will attend an outpatient clinic, fasted for at least 4 hours for collection of stool.
DIAGNOSTIC_TESTHealth-related Quality of life questionnairesParticipants will attend an outpatient clinic and complete validated healthy-related quality-of-life questionnaires.

Timeline

Start date
2022-03-09
Primary completion
2025-10-01
Completion
2025-12-01
First posted
2024-03-12
Last updated
2025-01-27

Locations

3 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06302660. Inclusion in this directory is not an endorsement.